Levels of anti-dsDNA fluctuate with changes in disease activity and, in combination with reduced levels of complement component (C)3 and C4 proteins, are strong indicators of disease flare in patients with SLE [6]. The gene discussed is C4A; the disease is systemic lupus erythematosus.